Results 181 to 190 of about 553,015 (386)

Placebos Without Deception: Outcomes, Mechanisms, and Ethics.

International review of neurobiology, 2018
L. Colloca, J. Howick
semanticscholar   +1 more source

Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is managed after sinus surgery with topical corticosteroids. Given limited distribution of nasal steroid sprays, patients have the option of either steroid nasal irrigation (SNI) or exhalation delivery system with fluticasone (EDS‐FLU).
Daniel Xiao, Martin J. Citardi, William C. Yao, Amber U. Luong   +3 more
wiley   +1 more source

The effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room [PDF]

Drugs altering susceptibility to motion sickness in aerobatics and slow rotation ...
Cawrse, A. C., Deane, F. R., Graybiel, A., Wood, C. D.   +3 more
core   +1 more source

Amantadine for olanzapine-induced weight gain: a systematic review and meta-analysis of randomized placebo-controlled trials

, 2012
Samir Kumar Praharaj, PSVN Sharma
openalex   +2 more sources

Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial – CORRIGENDUM [PDF]

, 2016
Shoji Shinkai, Masamichi Toba, Takao Saito, Ikutaro Sato, Mina Tsubouchi, Kiyoto Taira, Keiji Kakumoto, Takashi Inamatsu, Hiroto Yoshida, Yoshinori Fujiwara, Taro Fukaya, Tetsuya Matsumoto, Kazuhiro Tateda, Keizo Yamaguchi, Noriyuki Kohda, Shigeru Kohno   +15 more
openalex   +1 more source

Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent, often Type 2‐mediated inflammatory disease that markedly impairs quality of life. While dupilumab provides rapid improvement, there is limited evidence on long‐term outcomes beyond 2 years, and the clinical impact of dosing‐interval extension remains unclear.
Nicholas J. Campion, Dioni‐Pinelopi Petsiou, Florian C. Fally, Karina Berbalk, Noah F. Melamed, Aldine Tu, Christina Morgenstern, Fana Alem Kidane, Mohammed Zghaebi, Linda Liu, Minghao Pan, Tina J. Bartosik, Victoria Stanek, Katarina Gangl, Julia Eckl‐Dorna, Sven Schneider   +15 more
wiley   +1 more source

Placebo or no placebo? [PDF]

Nature, 1990
openaire   +1 more source

Bifeprunox versus placebo for schizophrenia [PDF]

, 2016
Arka Chattopadhyay, Stephen Frey, Ghiselle Green   +2 more
openalex   +1 more source

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

Proceedings of the Nutrition Society, 2017
H. Staudacher, P. Irving, M. Lomer, K. Whelan   +3 more
semanticscholar   +1 more source

Effect of Laser Posterior Nasal Neurolysis for the Treatment of Chronic Rhinitis: A Randomized Controlled Trial

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background To determine the safety and efficacy of laser ablation of the posterior nasal nerve (PNN) for the treatment of chronic rhinitis. Methods This study was a single‐center, prospective, single‐blinded, randomized sham‐controlled trial. Patients with a 24‐h reflective Total Nasal Symptom Score (rTNSS) ≧ 5, rhinorrhea ≧ 2, and congestion ≧
Jyun‐Yi Liao, En‐Ying Wang, Ying‐Shuo Hsu, Ming‐Shao Tsai, Cheng‐Jung Wu, Chia‐Hao Chang, Yi‐Li Hwang, Han‐Lo Teng, Jun‐Wei Hsieh, Chien‐Yu Huang   +9 more
wiley   +1 more source